These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7786612)

  • 21. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer and fenretinide, an analogue of vitamin A.
    Cobleigh MA
    Leukemia; 1994; 8 Suppl 3():S59-63. PubMed ID: 7808027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide.
    Formelli F; Barua AB; Olson JA
    FASEB J; 1996 Jul; 10(9):1014-24. PubMed ID: 8801162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients.
    Peng YM; Dalton WS; Alberts DS; Xu MJ; Lim H; Meyskens FL
    Int J Cancer; 1989 Jan; 43(1):22-6. PubMed ID: 2521335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences.
    Berni R; Formelli F
    FEBS Lett; 1992 Aug; 308(1):43-5. PubMed ID: 1386578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
    Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
    Guerrieri-Gonzaga A; Robertson C; Bonanni B; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Formelli F; Intra M; Latronico A; Franchi D; Pelosi G; Johnson K; Decensi A
    J Clin Oncol; 2006 Jan; 24(1):129-35. PubMed ID: 16382122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal retinal function associated with fenretinide, a synthetic retinoid.
    Kaiser-Kupfer MI; Peck GL; Caruso RC; Jaffe MJ; DiGiovanna JJ; Gross EG
    Arch Ophthalmol; 1986 Jan; 104(1):69-70. PubMed ID: 2935125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis.
    Chapman JS; Weiss KL; Curley RW; Highland MA; Clagett-Dame M
    Arch Biochem Biophys; 2003 Nov; 419(2):234-43. PubMed ID: 14592467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
    Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
    Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of breast cancer with retinoids.
    Veronesi U; De Palo G; Costa A; Formelli F; Marubini E; Del Vecchio M
    J Natl Cancer Inst Monogr; 1992; (12):93-7. PubMed ID: 1535505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
    Fabian CJ
    J Clin Oncol; 2009 Aug; 27(23):3734-6. PubMed ID: 19597020
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid.
    Swisshelm K; Ryan K; Tsuchiya K; Sager R
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4472-6. PubMed ID: 7538673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis in primary meningioma cultures by fenretinide.
    Puduvalli VK; Li JT; Chen L; McCutcheon IE
    Cancer Res; 2005 Feb; 65(4):1547-53. PubMed ID: 15735044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular toxic effects of fenretinide.
    Modiano MR; Dalton WS; Lippman SM; Joffe L; Booth AR; Meyskens FL
    J Natl Cancer Inst; 1990 Jun; 82(12):1063. PubMed ID: 2140863
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.
    Peyrat JP; Bonneterre J; Hecquet B; Vennin P; Louchez MM; Fournier C; Lefebvre J; Demaille A
    Eur J Cancer; 1993; 29A(4):492-7. PubMed ID: 8435198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM; Plante RK; Visconti V; Lau CY
    Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention of breast cancer with fenretinide.
    Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
    Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.